# Exposure to Non-Steady-State Oxygen Is Reflected in Changes to Arterial Blood Gas Values, Prefrontal Cortical Activity, and Systemic Cytokine Levels

**Authors:** Elizabeth G. Damato, Joseph S. Piktel, Seunghee P. Margevicius, Seth J. Fillioe, Lily K. Norton, Alireza Abdollahifar, Kingman P. Strohl, David S. Burch, Michael J. Decker

PMC · DOI: 10.3390/ijms25063279 · 2024-03-14

## TL;DR

Exposure to fluctuating oxygen levels affects blood gases, brain activity, and immune markers in aviators.

## Contribution

This study reveals how non-steady-state oxygen exposure impacts physiological and cognitive responses in aviators.

## Key findings

- Non-steady-state FiO2 exposure leads to higher PaO2 levels after exposure compared to steady-state conditions.
- Prefrontal cortical activation is reduced after exposure to non-steady-state FiO2 >50%.
- Serum cytokine levels increase 48 hours after non-steady-state FiO2 exposure.

## Abstract

Onboard oxygen-generating systems (OBOGSs) provide increased inspired oxygen (FiO2) to mitigate the risk of neurologic injury in high altitude aviators. OBOGSs can deliver highly variable oxygen concentrations oscillating around a predetermined FiO2 set point, even when the aircraft cabin altitude is relatively stable. Steady-state exposure to 100% FiO2 evokes neurovascular vasoconstriction, diminished cerebral perfusion, and altered electroencephalographic activity. Whether non-steady-state FiO2 exposure leads to similar outcomes is unknown. This study characterized the physiologic responses to steady-state and non-steady-state FiO2 during normobaric and hypobaric environmental pressures emulating cockpit pressures within tactical aircraft. The participants received an indwelling radial arterial catheter while exposed to steady-state or non-steady-state FiO2 levels oscillating ± 15% of prescribed set points in a hypobaric chamber. Steady-state exposure to 21% FiO2 during normobaria produced arterial blood gas values within the anticipated ranges. Exposure to non-steady-state FiO2 led to PaO2 levels higher upon cessation of non-steady-state FiO2 than when measured during steady-state exposure. This pattern was consistent across all FiO2 ranges, at each barometric condition. Prefrontal cortical activation during cognitive testing was lower following exposure to non-steady-state FiO2 >50% and <100% during both normobaria and hypobaria of 494 mmHg. The serum analyte levels (IL-6, IP-10, MCP-1, MDC, IL-15, and VEGF-D) increased 48 h following the exposures. We found non-steady-state FiO2 levels >50% reduced prefrontal cortical brain activation during the cognitive challenge, consistent with an evoked pattern of neurovascular constriction and dilation.

## Linked entities

- **Proteins:** IL6 (interleukin 6), CXCL10 (C-X-C motif chemokine ligand 10), CCL2 (C-C motif chemokine ligand 2), ADAM11 (ADAM metallopeptidase domain 11), IL15 (interleukin 15), VEGFD (vascular endothelial growth factor D)

## Full-text entities

- **Genes:** CCL22 (C-C motif chemokine ligand 22) [NCBI Gene 6367] {aka A-152E5.1, ABCD-1, DC/B-CK, MDC, SCYA22, STCP-1}, IL15 (interleukin 15) [NCBI Gene 3600] {aka IL-15}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, VEGFD (vascular endothelial growth factor D) [NCBI Gene 2277] {aka FIGF, VEGF-D}
- **Diseases:** neurovascular constriction (MESH:D013901), neurologic injury (MESH:D020196), diminished cerebral perfusion (MESH:D015354)
- **Chemicals:** Oxygen (MESH:D010100), FiO2 (-)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10969887/full.md

---
Source: https://tomesphere.com/paper/PMC10969887